Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Edgewise Therapeutics Inc

EWTX
Current price
22.42 USD +0.09 USD (+0.40%)
Last closed 22.33 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 814 966 016 USD
Yield for 12 month +210.53 %
1Y
3Y
5Y
10Y
15Y
EWTX
21.11.2021 - 28.11.2021

Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, EDG-5506, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders that is in Phase I clinical trials. In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado. Address: 1715 38th Street, Boulder, CO, United States, 80301

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

33.6 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

+2 252 000 USD

Current Year

-1 732 000 USD

Last Year

-538 000 USD

Current Quarter

-525 000 USD

Last Quarter

+1 719 000 USD

Key Figures EWTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -121 577 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -17.14 %
PEG Ratio
Return On Equity TTM -24.51 %
Wall Street Target Price 33.6 USD
Revenue TTM
Book Value 5.74 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.54 USD
Diluted Eps TTM -1.54 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics EWTX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History EWTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation EWTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -10.7546
Price Book MRQ 4.7807

Financials EWTX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators EWTX

For 52 weeks

5.12 USD 21.6 USD
50 Day MA 17.89 USD
Shares Short Prior Month 6 500 685
200 Day MA 13.2 USD
Short Ratio 13.88
Shares Short 7 618 578
Short Percent 12 %

Dynamics of changes in the value of assets

9

9985

6.13 HKD Weilong Delicious Global Hldg +0.01 (+1.66%)
Detailed analytics
H

HLX

12.12 USD Helix Energy Solutions Group Inc -0.33 (-2.65%)
Detailed analytics
N

NPNGY

8.14 USD Nippon Gas Co., Ltd. 0 (0%)
Detailed analytics
T

T0A

10.20 EUR TRULIEVE CANNABIS 0 (0%)
Detailed analytics
3

3IC

21.28 EUR Icade SA +0.07 (+0.28%)
Detailed analytics